AMBA vs MCHP vs CEVA vs SLAB vs ALGM

For growth investors, Silicon Laboratories Inc.

(SLAB) is the stronger pick with 34. 3% revenue growth year-over-year, versus -42. 3% for Microchip Technology Incorporated (MCHP). Analysts rate Ambarella, Inc. (AMBA) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Allegro MicroSystems, Inc.

(ALGM) delivered a total return of +93. 3%, compared to -35. 4% for CEVA, Inc. (CEVA). Over 10 years, the gap is even starker: SLAB returned +375. 0% versus CEVA's +27. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Silicon Laboratories Inc.

(SLAB) is the lower-risk stock at 1. 25β versus CEVA, Inc. 's 2. 76β — meaning CEVA is approximately 121% more volatile than SLAB relative to the S&P 500. On balance sheet safety, Ambarella, Inc. (AMBA) carries a lower debt/equity ratio of 1% versus 80% for Microchip Technology Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Silicon Laboratories Inc.

(SLAB) is pulling ahead at 34. 3% versus -42. 3% for Microchip Technology Incorporated (MCHP). On earnings-per-share growth, the picture is similar: Silicon Laboratories Inc. grew EPS 66. 6% year-over-year, compared to -150. 0% for Allegro MicroSystems, Inc.. Over a 3-year CAGR, ALGM leads at -1. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Microchip Technology Incorporated (MCHP) is the more profitable company, earning -0.

0% net margin versus -41. 1% for Ambarella, Inc. — meaning it keeps -0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MCHP leads at 6. 7% versus -44. 4% for AMBA. At the gross margin level — before operating expenses — CEVA leads at 88. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Microchip Technology Incorporated (MCHP) trades at 64.

8x forward P/E versus 95. 4x for Ambarella, Inc. — 30. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMBA: 32. 4% to $98. 33.

In this comparison, MCHP (1.

8% yield) pays a dividend. AMBA, CEVA, SLAB, ALGM do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Microchip Technology Incorporated (MCHP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.

8% yield, +373. 8% 10Y return). CEVA, Inc. (CEVA) carries a higher beta of 2. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MCHP: +373. 8%, CEVA: +27. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AMBA is a small-cap high-growth stock; MCHP is a mid-cap quality compounder stock; CEVA is a small-cap quality compounder stock; SLAB is a small-cap high-growth stock; ALGM is a small-cap quality compounder stock. MCHP pays a dividend while AMBA, CEVA, SLAB, ALGM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.